FDA Approved: TRAVOPROST OPHTHALMIC SOLUTION, 0.004% — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Mylan's travoprost ophthalmic solution 0.004% through an original application for lowering intraocular pressure in open-angle glaucoma or ocular hy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• TRAVOPROST OPHTHALMIC SOLUTION, 0.004% (travoprost ophthalmic solution 0.004%)

Snippet

ORIG AP for TRAVOPROST OPHTHALMIC SOLUTION, 0.004% (TRAVOPROST OPHTHALMIC SOLUTION, 0.004%)